This completed Phase 2a trial tested whether a sublingual tablet called MTX101 can safely relieve migraine pain in adults. 78 participants took either the drug or a placebo during a migraine attack and tracked their symptoms. The study measured pain reduction and the need for res…
Phase: PHASE2 • Sponsor: Manistee Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC